首页> 美国卫生研究院文献>International Journal of Immunopathology and Pharmacology >Evaluation of an oral appliance in patients with mild to moderate obstructive sleep apnea syndrome intolerant to continuous positive airway pressure use: Preliminary results
【2h】

Evaluation of an oral appliance in patients with mild to moderate obstructive sleep apnea syndrome intolerant to continuous positive airway pressure use: Preliminary results

机译:轻度至中度阻塞性呼吸暂停综合症患者对持续使用气道正压耐受性不佳的患者的口腔矫治器评估:初步结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obstructive sleep apnea syndrome (OSAS) is a phenomenon of repeated, episodic reduction, or cessation of airflow (hypopnea/apnea) as a result of upper airways obstruction. First-line treatment in younger children is adenotonsillectomy, although other available treatment options in middle-aged adults include continuous positive airways pressure (CPAP) and airway adjuncts. Oral appliances (OA) are a viable treatment alternative in patients with OSAS.The objective of this study was to assess, in a 1-year follow-up study, an OA in OSAS patients. The participants were subjected to polysomnographic examination with a validated device (MicroMESAM). Eight participants were fitted with a Thornton Adjustable Positioner (TAP). The participants were asked to wear the test appliance for 7 nights, and in case of compliance, for 6 months. The selected patients record their usage of the appliance and any adverse effects in a treatment journal. The research focused on the following outcomes: sleep apnea (i.e. reduction in the apnea/hypopnea index) and the effect of oral appliances on daytime function.In conclusion, the results suggest that OA have a definite role in the treatment of snoring and sleep apnea.
机译:阻塞性睡眠呼吸暂停综合症(OSAS)是由于上呼吸道阻塞而反复反复发作或减少气流(呼吸不足/呼吸暂停)的现象。年幼儿童的一线治疗是腺扁桃体切除术,尽管中年成人还有其他可用的治疗选择,包括持续气道正压通气(CPAP)和气道辅助治疗。口服矫治器(OA)是OSAS患者的一种可行的治疗选择。本研究的目的是在为期1年的随访研究中评估OSAS患者的OA。使用经过验证的设备(MicroMESAM)对参与者进行多导睡眠监测。八名参与者配备了桑顿可调式定位器(TAP)。要求参与者将测试设备穿戴7夜,并在遵守规定的情况下穿戴6个月。选定的患者在治疗日志中记录其使用该器具以及任何不良影响。该研究集中于以下结果:睡眠呼吸暂停(即呼吸暂停/呼吸不足指数的降低)以及口服矫治器对白天功能的影响。总之,结果表明,OA在打s和睡眠呼吸暂停的治疗中具有明确的作用。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号